Effect of Hematocrit and Elevated Beat Rate on the 12cc Penn State Pediatric Ventricular Assist Device

Sailahari V Ponnaluri1, Brady L Houtz1, Emma C Raich1

  • 1From the Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|August 7, 2023
PubMed

Insights

Pediatric ventricular assist devices (PVADs) show consistent flow fields across varying hematocrit and heart rates. Adjusting operating conditions can optimize PVAD performance and reduce clot risk in children.

Area of Science:

  • Biomedical Engineering
  • Pediatric Cardiology
  • Fluid Dynamics

Background:

  • Congenital heart disease (CHD) impacts ~40,000 US infants annually, with 25% needing intervention.
  • Pediatric ventricular assist devices (PVADs) serve as a critical bridge to transplant for children due to donor heart scarcity.
  • Existing PVADs are optimized for nominal conditions, but pediatric patients exhibit unique physiological variations like fluctuating hematocrit and heart rates.

Purpose of the Study:

  • To evaluate the performance of the 12cc pneumatic Penn State PVAD under pediatric-specific physiological conditions.
  • To investigate the impact of varying hematocrit and heart rates on flow dynamics and surface washing within the PVAD.
  • To determine if operational adjustments can mitigate risks of platelet adhesion and thrombus formation in pediatric patients.

Main Methods:

  • Utilized particle image velocimetry (PIV) to analyze fluid flow within the PVAD.
  • Employed three non-Newtonian blood analogs with hematocrit levels of 20%, 40%, and 60%.
  • Tested the device at two distinct beat rates: 75 bpm and 120 bpm, simulating pediatric heart rate variability.

Main Results:

  • Consistent flow field patterns, including an inlet jet and solid body rotation during diastole, were observed across all tested hematocrit levels and beat rates.
  • Higher velocity magnitudes were noted at 120 bpm compared to 75 bpm.
  • Minor variations in flow field timing and surface washing efficiency were associated with different hematocrit levels.

Conclusions:

  • The Penn State PVAD demonstrates robust flow characteristics irrespective of pediatric hematocrit or heart rate variability.
  • Effective surface washing, crucial for reducing platelet adhesion, can be achieved by optimizing PVAD operating conditions.
  • These findings support the potential for tailored PVAD operation to enhance safety and efficacy in pediatric CHD patients.